TTrialPathMatch Me to Trials
← Back to trials
RecruitingAnterior Uveitis (AU)Birdshot ChorioretinitisBehcet Disease

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

Eligible age

5–85 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of cells and proteins found in an eye condition called anterior uveitis. Anterior uveitis is a type of inflammation in the eye that can be caused by many different diseases of the body.

Sponsor: Oregon Health and Science University

You may qualify if…

  • 1. Uveitis Group: Eyes with active intraocular inflammation and a clinical diagnose of spondyloarthritis/HLA-B27 associated anterior uveitis, Juvenile Idiopathic Arthritis (JIA) associated chronic anterior uveitis, Herpes Simplex Virus (HSV) anterior uveitis, Birdshot chorioretinitis, Behcet disease uveitis, sarcoidosis associated uveitis, uveitis of any additional type, or uveitis masquerade.
  • 2. Posterior Vitreous Detachment Group: Eyes with vitreous floaters and posterior vitreous detachment (PVD).
  • 3. Healthy/Control Group: Healthy eyes with no history of uveitis, PVD, or previous eye surgery.

You may not qualify if…

  • 1. Inability to give informed consent.
  • 2. Inability to maintain stable fixation for OCT imaging.
  • 3. Inability to commit to required visits to complete the study.
  • 4. Pregnancy and breastfeeding.

Where it's recruiting

Oregon

Portland

Source: ClinicalTrials.gov · NCT07065747 · last updated 2025-07-17

Quantification & Classification of Inflammatory Cells in Uveitis Using · TrialPath